IMNM
Immunome, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.76
−1.47%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-48.4%
Return on equity
-45.0%
Return on assets
-51.1%
Return on invested capital
0.00x
Asset turnover
-$208.8M
Cash from operations
$4.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026